	Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial. JCO Precis Oncol Gilson C, Ingleby F, Gilbert DC, Parry MA, Atako NB, Ali A, Hoyle A, Clarke NW, Gannon M, Wanstall C, Brawley C, Mason MD, Malik Z, Simmons A, Loehr A, Parry-Jones A, Eeles R, Kote-Jarai Z, James ND, Amos C, Parmar MKB, Langley RE, Sydes MR, Attard G, Chowdhury S, STAMPEDE Investigators.. PMID: 35050761 [PubMed - as supplied by publisher]
	A Systematic Review and Meta-Analysis on the Predictive Value of Cell-Free DNA-Based Androgen Receptor Copy Number Gain in Patients With Castration-Resistant Prostate Cancer. JCO Precis Oncol Tolmeijer SH, Boerrigter E, Schalken JA, Geerlings MJ, van Oort IM, van Erp NP, Gerritsen WR, Ligtenberg MJL, Mehra N. PMID: 35050750 [PubMed - as supplied by publisher]
	Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. JAMA Oncol Kishan AU, Steigler A, Denham JW, Zapatero A, Guerrero A, Joseph D, Maldonado X, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Tosoian JJ, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Jiang T, Ma TM, Xiang M, Philipson R, Chang A, Kupelian PA, Rettig MB, Feng FY, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Boutros PC, Horwitz EM, Tendulkar RD, Spratt DE, Romero T. PMID: 35050303 [PubMed - as supplied by publisher]
	Characterization of Testicular Tumor Lesions in Dogs by Different Ultrasound Techniques. Animals (Basel) Orlandi R, Vallesi E, Boiti C, Polisca A, Bargellini P, Troisi A. PMID: 35049832 [PubMed - as supplied by publisher]
	Diagnostic and Therapeutic Challenges in a Patient with Synchronous Very High-Risk Prostate Adenocarcinoma and Anal Carcinoma. Curr Oncol Wallach J, Youssef I, Leaf A, Schwartz D. PMID: 35049707 [PubMed - as supplied by publisher]
	Prospective Randomized Phase II Study of Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionated Radiotherapy (CFRT) for Chinese Patients with Early-Stage Localized Prostate Cancer. Curr Oncol Poon DMC, Lam D, Wong KCW, Chu CM, Cheung M, Mo F, Suen J, Ng CF, Chan ATC. PMID: 35049677 [PubMed - as supplied by publisher]
	Increased risk of bladder cancer in young adult men with hyperlipidemia: A population-based cohort study. Medicine (Baltimore) Shih HJ, Lin KH, Wen YC, Fan YC, Tsai PS, Huang CJ. PMID: 35049242 [PubMed - as supplied by publisher]
	Accuracy and Challenges in the Vesical Imaging-Reporting and Data System for Staging Bladder Cancer. J Magn Reson Imaging Meng X, Hu H, Wang Y, Feng C, Hu D, Liu Z, Kamel IR, Li Z. PMID: 35049074 [PubMed - as supplied by publisher]
	Review of TFEB-amplified renal cell carcinoma with focus on clinical and pathobiological aspects. Pol J Pathol Kuroda N, Sugawara E, Ohe C, Kojima F, Ohashi R, Mikami S, Nagashima Y, Peckova K, Michal M, Hes O. PMID: 35048631 [PubMed - in process]
	Feasibility of in-office MRI-targeted partial gland cryoablation for prostate cancer: an IDEAL stage 2A study. BMJ Surg Interv Health Technol Basourakos SP, Al Hussein Al Awamlh B, Bianco FJ, Patel NA, Laviana A, Margolis DJ, Mosquera JM, McClure TD, Yu M, Hu JC. PMID: 35047795 [PubMed]
	Racial Disparities in Access to Prostate Cancer Clinical Trials: A County-Level Analysis. JNCI Cancer Spectr Wang WJ, Ramsey SD, Bennette CS, Bansal A. PMID: 35047752 [PubMed - in process]
	Management of acute kidney injury in gastrointestinal tumor: An overview. World J Clin Cases Su YQ, Yu YY, Shen B, Yang F, Nie YX. PMID: 35047588 [PubMed]
	Overall and Cancer-Specific Survival in Patients With Renal Pelvic Transitional Cell Carcinoma: A Population-Based Study. Front Med (Lausanne) Hu T, You S. PMID: 35047518 [PubMed]
	The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study. Front Oncol Wang S, Ji Y, Chen Y, Du P, Cao Y, Yang X, Ma J, Yu Z, Yang Y. PMID: 35047413 [PubMed]
	Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR). Clinicoecon Outcomes Res Musat MG, Kwon CS, Masters E, Sikirica S, Pijush DB, Forsythe A. PMID: 35046678 [PubMed]
	Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trials. Urol Oncol Gabrielson AT, Daniels MJ, Rowe J, Alam R, Lee EJ, Matoso A, De Felice A, Hahn N, Hoffman-Censits J, Bivalacqua TJ, Kates M. PMID: 35045949 [PubMed - as supplied by publisher]
	Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation. Cancer Cell Int Quan Y, Zhang X, Ping H. PMID: 35045837 [PubMed]
	PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer. Appl Clin Inform Tamposis I, Tsougos I, Karatzas A, Vassiou K, Vlychou M, Tzortzis V. PMID: 35045583 [PubMed - in process]
	A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study). Oncol Res Treat Grünwald V, Hilser T, Meiler J, Goebell PJ, Ivanyi P, Strauss A, Hartmann A, Bedke J, Bergmann L. PMID: 35045416 [PubMed - as supplied by publisher]
	Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer. Hum Cell Zhang Z, Liang Z, Li D, Wang L, Chen Y, Liang Y, Jiao W, Niu H. PMID: 35044630 [PubMed - as supplied by publisher]

Articles 1 - 20 / 142315

Page 1 of 7116



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy